PROFOUND MEDICAL CORP. Income (Loss) from Continuing Operations before Income Taxes, Domestic
PROFOUND MEDICAL CORP. (PROF) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$43.37 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-05
- PROFOUND MEDICAL CORP. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$43.37M.
- PROFOUND MEDICAL CORP. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$28.29M.
- PROFOUND MEDICAL CORP. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$29.35M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$43.37M 10-K · filed 2026-03-05 |
| 2024-12-31 | -$28.29M 10-K · filed 2026-03-05 |
| 2023-12-31 | -$29.35M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |